Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Oscar Health, Inc. (OSCR) reported a Q3 loss of $0.22 per share, slightly worse than the Zacks Consensus Estimate of a $0.20 loss. However, the company topped revenue estimates.
November 07, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Oscar Health reported a Q3 loss of $0.22 per share, missing the Zacks Consensus Estimate by $0.02. Despite the earnings miss, the company exceeded revenue expectations.
The earnings per share (EPS) was slightly below expectations, which could have a negative impact on the stock price. However, the fact that revenue estimates were exceeded may offset the negative EPS impact, leading to a neutral short-term effect on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100